SCHEMBL18566148

SCHEMBL18566148

Cn1c2ccccc2c2ccc3c(sc4ccc5ccccc5c43)c21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRNP P04156 1/20 0.46
▸ ALKBH5 Q6P6C2 1/20 0.44
▸ FTO Q9C0B1 1/20 0.44
▸ MAPT P10636 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ GPR3 P46089 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.40
▸ IDO1 P14902 1/20 0.40
▸ RAB9A P51151 2/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ HPGD P15428 2/20 0.36
▸ CASP1 P29466 2/20 0.36
▸ CASP7 P55210 2/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ GABRP O00591 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15126964 0.81 TDP1 (0.39) PRNPKDM4ERAB9AHSD17B10HPGD
SCHEMBL15126959 0.81 ATM (0.45) PRNPKDM4ERAB9AHSD17B10HPGD
SCHEMBL13183677 0.80 ALKBH5 (0.50) ALKBH5FTOMAPTKDM4EGPR3
SCHEMBL18566128 0.80 ALKBH5 (0.44) PRNPALKBH5FTOMAPTKDM4E
SCHEMBL23966487 0.80 ALKBH5 (0.53) PRNPALKBH5FTOMAPTKDM4E
SCHEMBL18566124 0.79 PRNP (0.41) PRNPMAPTKDM4EGPR3RAB9A
SCHEMBL257568 0.78 ALKBH5 (0.58) PRNPALKBH5FTOMAPTKDM4E
SCHEMBL13789873 0.78 HPRT1 (0.48) PRNPGPR3RAB9AHSD17B10HPGD
SCHEMBL15126960 0.78 PRNP (0.33) PRNPMAPTCYP3A4MAPK1LMNA
SCHEMBL21708960 0.78 ALDH1A1 (0.33) PRNPMAPTKDM4EHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 PRNP 2653/4885ALKBH5 265/4885FTO 202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback